Notes
The study was funded by Ipsen Pharma.
Reference
Abogunrin S, et al. AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis. ClinicoEconomics and Outcomes Research : 9 Sep 2015. Available from: URL: http://dx.doi.org/10.2147/CEOR.S86355
Rights and permissions
About this article
Cite this article
AbobotulinumtoxinA cost-saving option for cervical dystonia. PharmacoEcon Outcomes News 737, 7 (2015). https://doi.org/10.1007/s40274-015-2453-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2453-7